These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 15249675)

  • 21. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
    Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A
    J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance.
    Waisman A; Yogev N
    Eur J Immunol; 2009 Jun; 39(6):1448-51. PubMed ID: 19499529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
    Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
    Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis.
    Gary R; Voelkl S; Palmisano R; Ullrich E; Bosch JJ; Mackensen A
    J Immunol; 2012 Jan; 188(2):744-52. PubMed ID: 22174448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
    Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
    J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of B7-H1 in inflammatory renal tubular epithelial cells.
    Chen Y; Zhang J; Li J; Zou L; Zhao T; Tang Y; Wu Y
    Nephron Exp Nephrol; 2006; 102(3-4):e81-92. PubMed ID: 16282703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
    Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
    Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.
    Eppihimer MJ; Gunn J; Freeman GJ; Greenfield EA; Chernova T; Erickson J; Leonard JP
    Microcirculation; 2002 Apr; 9(2):133-45. PubMed ID: 11932780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.
    Dong H; Strome SE; Matteson EL; Moder KG; Flies DB; Zhu G; Tamura H; Driscoll CL; Chen L
    J Clin Invest; 2003 Feb; 111(3):363-70. PubMed ID: 12569162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
    Haspot F; Fehr T; Gibbons C; Zhao G; Hogan T; Honjo T; Freeman GJ; Sykes M
    Blood; 2008 Sep; 112(5):2149-55. PubMed ID: 18577709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
    Salama AD; Chitnis T; Imitola J; Ansari MJ; Akiba H; Tushima F; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Exp Med; 2003 Jul; 198(1):71-8. PubMed ID: 12847138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis.
    Ren Y; Lu L; Guo TB; Qiu J; Yang Y; Liu A; Zhang JZ
    J Immunol; 2008 Jul; 181(2):1491-8. PubMed ID: 18606704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.